There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Edwards Lifesciences Corp (EW) shows that investor sentiment remained same, with the stock’s consolidated last price to $66.24. The Edwards Lifesciences Corp has recorded 132,236 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION.
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $66.24 and fluctuated between $67.23 as its day high and $65.94 as its day low. The current market capitalization of Edwards Lifesciences Corp is $40.17B. A total of 2.6 million shares were traded on the day, compared to an average of 3.96M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, EW has seen 14 BUY and 15 SELL insider trades, representing the acquisition of 181,319 and the disposition of 178,860 shares. Over the last 12 months, there were 90 BUYs and 116 SELLs from insiders. Insiders purchased 1,113,290 shares during that period but sold 943,007.
In the most recent transaction, MUSSALLEM MICHAEL A sold 29,350 shares of EW for 67.18 per share on Nov 03. After the transaction, the Director now owns 4,486 company shares. In a previous transaction on Oct 31, Ullem Scott B. sold 7,255 shares at 62.66 per share. EW shares that CVP, Chief Financial Officer owns now total 19,248.
Among the insiders who sold shares, Wood Larry L disposed of 8,660 shares on Oct 13 at a per-share price of $70.00. This resulted in the Global President TAVR & Surg holding 213,794 shares of EW after the transaction. In another insider transaction, BOBO DONALD E JR sold 5,000 shares at $69.98 per share on Oct 13. Company shares held by the CVP,Strategy/Corp Development now total 39,503.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for EW in the last 3 months, the mean price target is $80.47 with high estimates of $102.00 and low estimates of $63.00. In terms of 52-week highs and lows, EW has a high of $94.87 and a low of $60.57.
As of this writing, EW has an earnings estimate of $0.59 per share for the current quarter. EPS was calculated based on a consensus of 25 estimates, with a high estimate of $0.61 per share and a lower estimate of $0.57. The company reported an EPS of $0.62 in the last quarter, which was 1.60% higher than expectations of $0.61.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EW’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $690.30M in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $10.98, while its Total Shareholder’s Equity was $5.84B.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Buy with a score of 4.10.